Brief: Sana Biotechnology Q4 Adjusted EPS USD -0.35 Vs. IBES Estimate USD -0.38
29/02/2024 21:05
Feb 29 (Reuters) - Sana Biotechnology Q4 adjusted net income USD -69.065 million. * Q4 EPS USD -0.45 * Q4 net income USD -88.117 million * Q4 operating expenses USD 90.619 million
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17